Hiring Freeze Will Affect FDA Commissioner, ORM Director Appointments
This article was originally published in The Tan Sheet
Executive Summary
Acting FDA Commissioner Bernard Schwetz, PhD, will continue to make funding the agency's science base a top priority, he stresses in a Jan. 22 email to agency staff.
You may also be interested in...
CDER Deputy Director Galson To Head Drug Center For Several Months
Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, will serve as the center's acting director for the next several months
NCCAM Intramural, International Research Directors Named
The National Center for Complementary & Alternative's Medicine's new intramural research program is likely to reflect, in part, its clinical director's expertise in the endocrinology of aging.
FDA Reviewer Retention Remains Priority In FY 2001 - User Fee Report
FDA will implement ideas from employee focus groups in FY 2001 to try to improve the retention rate in its drug review divisions, the agency said in its fiscal 2000 Prescription Drug User Fee Act Financial Report.